BSX
BOSTON SCIENTIFIC CORP
BOSTON SCIENTIFIC CORP (BSX) has 14 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 2, 2026.
Insiders have net bought $554K over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Michael F. Mahoney
- Employees:53,000
- HQ:Marlborough, MA, US
- IPO:1992-05-19
Insider Buying
$554K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$64.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Habiger David CFirst filing | Director | Purchase | 2,200 | $125K | May 21 | SEC ↗ |
Habiger David CFirst filing | Director | Purchase | 2,250 | $126K | May 21 | SEC ↗ |
Pegus CherylFirst filing | Director | Purchase | 1,770 | $100K | May 21 | SEC ↗ |
LUDWIG EDWARD JFirst filing | Director | Purchase | 3,580 | $203K | May 21 | SEC ↗ |
Congress trading BSX
See timeline →- RSen. John BoozmanSale$1,001 - $15,0002026-06-04
- DRep. Ro KhannaPurchase$1,001 - $15,0002026-06-02
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-06-05
- DRep. Gilbert CisnerosSale$1,001 - $15,0002026-06-05
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-29
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-19
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
BOSTON SCIENTIFIC CORP is in the Healthcare sector.